The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP1259562
WO Application Number:
US2000034793
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP00988240.8
WO Publication Number:
WO2001046291
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
20/12/2000
Grant date:
15/02/2006
EP Publication Date:
15/02/2006
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
15/02/2006
EP B1 Publication Date:
15/02/2006
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
19/12/2020
Lapsed By Expiration Date:
20/12/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
31/12/2010
Name:
Nektar Therapeutics
Address:
150 Industrial Road, 94070-6256, San Carlos, California, United States of America (US)
Historical Applicant/holder
From:
15/02/2006
To:
31/12/2010
Name:
Nektar Therapeutics Al, Corporation
Address:
490 Discovery Drive, 35806-2902, Huntsville, Alabama, United States of America (US)